GSRX Industries Inc. (GSRX)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 100.0% |
| 2019 | -0.78 USD | -110.81% |
| 2018 | -0.37 USD | 72.18% |
| 2017 | -1.33 USD | -269.44% |
| 2016 | -0.36 USD | -5.88% |
| 2015 | -0.34 USD | -6.25% |
| 2014 | -0.32 USD | -6.67% |
| 2013 | -0.30 USD | -7.14% |
| 2012 | -0.28 USD | 0.0% |
| 2011 | -0.28 USD | -7.69% |
| 2010 | -0.26 USD | -8.33% |
| 2009 | -0.24 USD | -20.0% |
| 2008 | -0.20 USD | -81.82% |
| 2007 | -0.11 USD | -416.43% |
| 2006 | -0.02 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 FY | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 Q3 | -0.04 USD | -1083.78% |
| 2020 Q2 | 0.00 USD | 23.33% |
| 2020 FY | - USD | 100.0% |
| 2020 Q1 | 0.00 USD | 101.76% |
| 2019 FY | - USD | -110.81% |
| 2019 Q4 | -0.17 USD | 58.54% |
| 2019 Q3 | -0.41 USD | -1005.12% |
| 2019 Q2 | -0.04 USD | 44.63% |
| 2019 Q1 | -0.07 USD | -5.51% |
| 2018 Q4 | -0.06 USD | -64.94% |
| 2018 Q2 | -0.03 USD | 85.33% |
| 2018 Q1 | -0.21 USD | 61.11% |
| 2018 FY | - USD | 72.18% |
| 2018 Q3 | -0.04 USD | -25.0% |
| 2017 Q3 | -0.02 USD | 89.0% |
| 2017 FY | - USD | -269.44% |
| 2017 Q1 | -0.10 USD | -10.54% |
| 2017 Q4 | -0.54 USD | -2354.55% |
| 2017 Q2 | -0.20 USD | -102.84% |
| 2016 FY | - USD | -5.88% |
| 2016 Q3 | -0.08 USD | 3.11% |
| 2016 Q4 | -0.09 USD | -5.94% |
| 2016 Q2 | -0.09 USD | 8.81% |
| 2016 Q1 | -0.10 USD | -12.51% |
| 2015 Q3 | -0.08 USD | -1.51% |
| 2015 FY | - USD | -6.25% |
| 2015 Q4 | -0.08 USD | -4.83% |
| 2015 Q2 | -0.08 USD | 12.43% |
| 2015 Q1 | -0.09 USD | -13.77% |
| 2014 FY | - USD | -6.67% |
| 2014 Q4 | -0.08 USD | -3.77% |
| 2014 Q1 | -0.09 USD | -16.96% |
| 2014 Q3 | -0.08 USD | 1.91% |
| 2014 Q2 | -0.08 USD | 8.93% |
| 2013 Q4 | -0.07 USD | -0.68% |
| 2013 Q3 | -0.07 USD | -2.81% |
| 2013 Q2 | -0.07 USD | 17.97% |
| 2013 Q1 | -0.09 USD | -29.55% |
| 2013 FY | - USD | -7.14% |
| 2012 Q3 | -0.08 USD | -29.88% |
| 2012 Q4 | -0.07 USD | 12.42% |
| 2012 Q1 | -0.08 USD | -12.18% |
| 2012 Q2 | -0.06 USD | 26.47% |
| 2012 FY | - USD | 0.0% |
| 2011 Q2 | -0.06 USD | 25.52% |
| 2011 Q3 | -0.06 USD | 0.49% |
| 2011 Q4 | -0.07 USD | -17.05% |
| 2011 FY | - USD | -7.69% |
| 2011 Q1 | -0.08 USD | -35.58% |
| 2010 Q1 | -0.08 USD | -48.35% |
| 2010 Q3 | -0.06 USD | -1.05% |
| 2010 Q4 | -0.06 USD | -5.57% |
| 2010 FY | - USD | -8.33% |
| 2010 Q2 | -0.06 USD | 29.49% |
| 2009 Q4 | -0.05 USD | 5.88% |
| 2009 Q2 | -0.06 USD | 23.86% |
| 2009 Q1 | -0.07 USD | -7.41% |
| 2009 FY | - USD | -20.0% |
| 2009 Q3 | -0.06 USD | -4.71% |
| 2008 Q4 | -0.07 USD | -22.95% |
| 2008 FY | - USD | -81.82% |
| 2008 Q1 | -0.05 USD | 75.58% |
| 2008 Q2 | -0.04 USD | 23.49% |
| 2008 Q3 | -0.05 USD | -54.65% |
| 2007 Q2 | -0.03 USD | -12.86% |
| 2007 FY | - USD | -416.43% |
| 2007 Q1 | -0.03 USD | 0.0% |
| 2007 Q3 | -0.00 USD | 91.14% |
| 2007 Q4 | -0.19 USD | -6685.71% |
| 2006 FY | - USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioQuest Corp. | - USD | NaN% |
| High Sierra Technologies, Inc. | -0.02 USD | 100.0% |
| Instadose Pharma Corp. | - USD | NaN% |